LCO 5589 \\PRDFS1\SCOUSERS\FORZANOF\WS\2019SB-00033-R02-
SB.docx
1 of 2
General Assembly Committee Bill No. 33
January Session, 2019
LCO No. 5589
Referred to Committee on INSURANCE AND REAL ESTATE
Introduced by:
(INS)
AN ACT CONCERNING HE ALTH INSURANCE COVER AGE OF
ORALLY AND INTRAVENO USLY ADMINISTERED PR ESCRIPTION
DRUGS.
Be it enacted by the Senate and House of Representatives in General
Assembly convened:
Section 1. (NEW) (Effective January 1, 2020) Each individual health 1
insurance policy providing coverage of the type specified in 2
subdivisions (1), (2), (4), (11), (12) and (16) of section 38a-469 of the 3
general statutes delivered, issued for delivery, renewed, amended or 4
continued in this state on or after January 1, 2020, providing coverage 5
for prescription drugs shall provide coverage for orally administered 6
prescription drugs on a basis that is no less favorable than the basis on 7
which such policy provides coverage for intravenously administered 8
prescription drugs. 9
Sec. 2. (NEW) (Effective January 1, 2020) Each group health insurance 10
policy providing coverage of the type specified in subdivisions (1), (2), 11
(4), (11), (12) and (16) of section 38a-469 of the general statutes 12
delivered, issued for delivery, renewed, amended or continued in this 13
state on or after January 1, 2020, providing coverage for prescription 14
drugs shall provide coverage for orally administered prescription 15 Committee Bill No. 33
LCO 5589 {\\PRDFS1\SCOUSERS\FORZANOF\WS\2019SB-00033-
R02-SB.docx }
2 of 2
drugs on a basis that is no less favorable than the basis on which such 16
policy provides coverage for intravenously administered prescription 17
drugs. 18
This act shall take effect as follows and shall amend the following
sections:
Section 1 January 1, 2020 New section
Sec. 2 January 1, 2020 New section
INS Joint Favorable